ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 104 filers reported holding ALX ONCOLOGY HLDGS INC in Q2 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $96,263 | -59.9% | 21,297 | +0.0% | 0.00% | – |
| Q4 2022 | $239,973 | -4.0% | 21,293 | -18.8% | 0.00% | – |
| Q3 2022 | $250,000 | +106.6% | 26,233 | +73.1% | 0.00% | – |
| Q2 2022 | $121,000 | -49.6% | 15,157 | +6.6% | 0.00% | – |
| Q1 2022 | $240,000 | -19.2% | 14,217 | +2.8% | 0.00% | – |
| Q4 2021 | $297,000 | -8.3% | 13,834 | +216.0% | 0.00% | – |
| Q3 2021 | $324,000 | +44.6% | 4,378 | +6.6% | 0.00% | – |
| Q2 2021 | $224,000 | -50.4% | 4,107 | -33.0% | 0.00% | – |
| Q1 2021 | $452,000 | -61.3% | 6,133 | -54.7% | 0.00% | -100.0% |
| Q4 2020 | $1,168,000 | – | 13,544 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $109,318,155 | 33.89% |
| Vivo Capital, LLC | 4,220,048 | $47,560 | 5.48% |
| Logos Global Management LP | 2,349,600 | $26,479,992 | 3.10% |
| Samsara BioCapital, LLC | 262,786 | $2,961,598 | 0.64% |
| Orbimed Advisors | 2,871,000 | $32,356,170 | 0.62% |
| Pier Capital, LLC | 271,848 | $3,063,727 | 0.50% |
| Cormorant Asset Management, LP | 612,079 | $6,898 | 0.46% |
| Nan Fung Group Holdings Ltd | 41,950 | $472,777 | 0.33% |
| Artal Group S.A. | 500,000 | $5,635 | 0.32% |
| Redmile Group, LLC | 607,470 | $6,846,187 | 0.28% |